| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/03/1994 | WO1994002132A1 Treatment of skin diseases |
| 02/03/1994 | WO1994002131A1 Treatment of herpetic diseases |
| 02/03/1994 | WO1994002130A1 Control of wound scar production with calcium antagonists alone or in a combination with a steroid |
| 02/03/1994 | WO1994002129A1 Veterinary medicinal anthelmintic preparation containing nitroscanate |
| 02/03/1994 | WO1994002128A1 USE OF α,w DICARBOXYLIC ACIDS AS FIBRINOGEN REDUCERS |
| 02/03/1994 | WO1994002127A1 A method of increasing creatine supply depot |
| 02/03/1994 | WO1994002126A1 Compositions and methods for topical treatment of skin lesions |
| 02/03/1994 | WO1994002125A1 Method for preventing and treating a viral condition by inhibiting membrane fusion |
| 02/03/1994 | WO1994002124A1 Anti-hiv agent |
| 02/03/1994 | WO1994002108A1 Chemotherapy for cancer |
| 02/03/1994 | WO1994002107A2 Method and medicament for inhibiting neutrophil elastase and cathepsin g |
| 02/03/1994 | WO1994002106A1 Therapeutic and diagnostic use of modified polymeric microcapsules |
| 02/03/1994 | WO1994002035A1 Food products containing benzimidazole |
| 02/03/1994 | WO1993024096A3 Use of n-(2-(dimethylamino)ethyl)acridine-4-carboxamide and its analogues for cancer treatment |
| 02/03/1994 | WO1993010741A3 Sex steroid activity inhibitors |
| 02/03/1994 | DE4324944A1 Use of 1,3-di:propyl-7H-purin-2,6-di:one derivs. - for treatment of the symptoms of cystic fibrosis and to restore the electrolyte balance of the cells |
| 02/03/1994 | DE4301783C1 Transdermal system per admin. of galanthamine - esp. for treatment of Alzheimer's disease and alcohol addiction |
| 02/03/1994 | DE4218292C1 Verwendung eines Arzneimittels mit einem Gehalt an Mestanolon und/oder 4-Chlor-1-dehydromethyltestosteron Use of a pharmaceutical having a content of mestanolone and / or 4-chloro-1-dehydromethyltestosteron |
| 02/03/1994 | CA2490644A1 Hybrid oligonucleotide phosphorothioates |
| 02/03/1994 | CA2141301A1 Esterification process |
| 02/03/1994 | CA2141214A1 Hydroxamic acid derivatives and their use as anti-inflammatory compounds |
| 02/03/1994 | CA2140931A1 Non-peptidic surrogates of the ldv sequence and their use in the treatment of inflammation, autoimmune disease and tumour progression |
| 02/03/1994 | CA2140924A1 Bis-staurosporine and k-252a derivatives |
| 02/03/1994 | CA2140852A1 Ng-monomethyl-l-arginine hydrochloride derivatives and their use in the treatment of septic shock |
| 02/03/1994 | CA2140760A1 Nutritional product for persons having a neurological injury |
| 02/03/1994 | CA2140669A1 Pseudo-half-knot rna formation by hybridization of antisense oligonucleotides to target rna's secondary structure |
| 02/03/1994 | CA2140662A1 Tetracyclic compounds, process and intermediates for their preparation and their use as antitumour agents |
| 02/03/1994 | CA2140630A1 Novel bioactive compositions, preparation and use thereof |
| 02/03/1994 | CA2140542A1 Oligonucleotide alkylphosphonothioates |
| 02/03/1994 | CA2140453A1 Novel diazabicycloalkenes and processes for the preparation thereof |
| 02/03/1994 | CA2140427A1 A two component fibrin-glue composition for improving in vitro fertilization |
| 02/03/1994 | CA2140352A1 Anti-hiv agent |
| 02/03/1994 | CA2140346A1 Pesticidal pyrimidine compounds |
| 02/03/1994 | CA2140343A1 Method and reagent for treatment of animal diseases |
| 02/03/1994 | CA2140333A1 Therapeutic and diagnostic use of modified polymeric microcapsules |
| 02/03/1994 | CA2140293A1 Radioimaging and radiochemotherapy phenolic thioether amines and acyl derivatives thereof for use in diagnosing and treating pigmentation disorders |
| 02/03/1994 | CA2140274A1 Treatment of physiological conditions with degassed perfluorocarbon liquid |
| 02/03/1994 | CA2140258A1 Food products containing benzimidazole |
| 02/03/1994 | CA2140243A1 Derivatives of 16-membered ring antibiotic macrolides |
| 02/03/1994 | CA2140241A1 Blood levels of cck peptides relative to panic disorder treatment |
| 02/03/1994 | CA2140237A1 Antiviral combinations |
| 02/03/1994 | CA2140229A1 N-cycloalkylpiperazine derivatives, methods of obtaining them and pharmaceutical compositions containing them |
| 02/03/1994 | CA2140135A1 Quinoline and naphthyridine prodrugs |
| 02/03/1994 | CA2140018A1 Pyrimidine compounds used in the therapy |
| 02/03/1994 | CA2139779A1 Substituted biphenylmethylimidazopyridines |
| 02/03/1994 | CA2139586A1 New pyridine derivatives as leukcotriene b antagonists |
| 02/03/1994 | CA2138650A1 Azacyclic compounds |
| 02/03/1994 | CA2138649A1 Imidazole, triazole and tetrazole derivatives |
| 02/03/1994 | CA2138128A1 Use of .alpha.-w-dicarboxylic acids as fibrinogen sinkers |
| 02/03/1994 | CA2136837A1 1-azaadamantane derivatives as 5-ht agonists or antagonists |
| 02/02/1994 | EP0581677A1 Cycloalkylalkylamines which are sigma-receptor ligands, process for preparing them and their application in therapy |
| 02/02/1994 | EP0581652A1 Pradimicins T1 and T2 and 11-0-dexylosylpradimicin T1, new members of the pradimicin family of antibiotics |
| 02/02/1994 | EP0581552A2 Triazolylthiomethylthio cephalosporin hyrochloride, its crystalline hydrate and the production of the same |
| 02/02/1994 | EP0581538A1 4-Substituted 1,2,4-triazole derivatives |
| 02/02/1994 | EP0581500A1 Antibiotic carbapenem compounds |
| 02/02/1994 | EP0581457A1 Use of cytisine compounds for the manufacture of a medicament for the treatment of neurodegenerative diseases |
| 02/02/1994 | EP0581456A1 Use of phenylpyrrolidines for the manufacture of a medicament for the treatment of neurodegenerative diseases |
| 02/02/1994 | EP0581282A1 Use of lipid-bound glycosaminoglyrans for the treatment of rheumatoid arthritis |
| 02/02/1994 | EP0581187A1 Oxime derivatives |
| 02/02/1994 | EP0581167A1 Novel arylglycinamide derivatives and preparative processes therefor and their use for treatment of dysuria |
| 02/02/1994 | EP0581166A1 Benzimidazoles, process for their preparation and their use as angiotensin-II antagonists |
| 02/02/1994 | EP0581165A2 Acrylamide derivatives as antirussive agent |
| 02/02/1994 | EP0581107A1 Method of preparation of physostigmine carbamate derivatives from eseretholes |
| 02/02/1994 | EP0581106A1 Substituted aminothienopyridines, a process for their preparation and their use as medicaments |
| 02/02/1994 | EP0581079A1 Particular 1,4-dihydropyridine-3,5-dicarboxylic acid ester, process for its preparation and its pharmaceutical use |
| 02/02/1994 | EP0581062A1 Use of 1,2,5-oxadiazole-2-oxides for the manufacture of a medicament for the treatment of erectile dysfunctions |
| 02/02/1994 | EP0581003A1 Imidazolyl substituted cyclohexane derivatives |
| 02/02/1994 | EP0580968A2 Vitamin D3 fluorinated analogs |
| 02/02/1994 | EP0580916A1 N(1) substituted pyrazino 2,3-c -1,2,6-thiadiazine 2,2-dioxides and their use as pharmaceuticals |
| 02/02/1994 | EP0580814A1 Antibacterial mild liquid skin cleanser |
| 02/02/1994 | EP0580812A1 Anti-tumor and anti-psoriatic agents |
| 02/02/1994 | EP0580795A1 Antisense oligonucleotides to c-kit proto-oncogene and uses thereof |
| 02/02/1994 | EP0580790A1 Method for potentiating primary drugs in treating multidrug resistant cells |
| 02/02/1994 | EP0580782A1 An anti-hiv protein, tap 29, from trichosanthes, dna coding therefor and therapeutic uses thereof. |
| 02/02/1994 | EP0580778A1 Convertible microemulsion formulations |
| 02/02/1994 | EP0580776A1 Use of sigma receptor antagonists to enhance the effects of antipsychotic drugs |
| 02/02/1994 | EP0580774A1 Vitamin d derivatives comprising a lateral chain expoxide group |
| 02/02/1994 | EP0580763A1 Compositions and methods for endothelial binding |
| 02/02/1994 | EP0580759A1 Methods and compositions for isolating taxanes |
| 02/02/1994 | EP0580754A1 Oligodeoxynucleotides and oligonucleotides useful as decoys for proteins which selectively bind to defined dna sequences |
| 02/02/1994 | EP0580739A1 Method for detecting and treating alzheimer's disease |
| 02/02/1994 | EP0580738A1 7-chromanyl esters of phenols and benzoic acids having retinoid-like activity. |
| 02/02/1994 | EP0580658A1 Nabumetone powders |
| 02/02/1994 | EP0580657A1 Use of guanine derivative or a prodrug thereof in the treatment of hiv-1 infection |
| 02/02/1994 | EP0580650A1 Novel 2-spirocyclopropyl 4-acylcephems and processes for the preparation thereof |
| 02/02/1994 | EP0580644A1 1,3,4-trisubstituted piperidine derivatives, their production and use. |
| 02/02/1994 | EP0580633A1 Heterocyclic amines useful in the therapy of asthma and inflammation of the respiratory tract |
| 02/02/1994 | EP0580632A1 Antibiotic carbapenem derivatives |
| 02/02/1994 | EP0580627A1 Pharmaceutical composition for the treatment of gastritis |
| 02/02/1994 | EP0580616A1 New active compounds |
| 02/02/1994 | EP0580609A1 Pharmaceutical xanthone derivatives |
| 02/02/1994 | EP0580598A1 Styryl-substituted heteroaryl compounds which inhibit egf receptor tyrosine kinase |
| 02/02/1994 | EP0528968B1 (3-alkylthio propyl)-3 benzothiazoline derivatives, preparation thereof and drugs containing said derivatives |
| 02/02/1994 | EP0489043B1 Use of the (+)-enantiomer of anipamil |
| 02/02/1994 | EP0478558B1 An improved process for the preparation of substituted isoflavone derivatives |
| 02/02/1994 | EP0450021B1 Anti-cancer compounds |
| 02/02/1994 | EP0442958B1 Pharmaceutical composition for ophthalmic use comprising a water soluble acid addition salt of ibopamine |
| 02/02/1994 | EP0432209B1 Phenylpyrrolic compounds used as drugs, their preparation and application |
| 02/02/1994 | EP0393066B1 Cephalosporin antibiotics |
| 02/02/1994 | EP0378657B1 Oxazolidinone penetration enhancing compounds |